This R03 Funding Opportunity, offered by the NIH, encourages institutions and organizations to submit applications for multidisciplinary, investigator-initiated basic and translational research. The primary focus is on developmental pharmacology and toxicology. This grant specifically emphasizes the crucial role of ontogeny, the process of individual development, on vital biological components. These include drug metabolizing enzymes, various transporters, receptors, and signaling pathways. Proposed research must investigate how these elements function and change across significant developmental periods, specifically from fetal life through adolescence. Understanding their influence on drug action and potential toxicity during these critical stages is paramount. The ultimate aim is to advance knowledge in how development impacts drug effectiveness and safety.
Opportunity ID: 239456
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-13-307 |
| Funding Opportunity Title: | Developmental Pharmacology and Toxicology: Role of Ontogeny (R03) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Environment Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.113 — Environmental Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 07, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2016 |
| Current Closing Date for Applications: | Sep 07, 2016 |
| Archive Date: | Oct 08, 2016 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $50,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) City or township governments Public and State controlled institutions of higher education Private institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Independent school districts Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages grant applications from institutions or organizations that propose multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology and toxicology. Particular emphasis should be placed on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways across developmental periods from fetal life to adolescence affecting drug action and toxicity. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-13-307.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | Forms-C | PKG00182651 | Sep 16, 2013 | May 07, 2016 | View | |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00222678 | May 16, 2016 | Sep 07, 2016 | View |
Package 1
Mandatory forms
239456 RR_SF424_2_0-2.0.pdf
239456 PHS398_ResearchPlan_2_0-2.0.pdf
239456 PHS398_CoverPageSupplement_2_0-2.0.pdf
239456 RR_KeyPersonExpanded_2_0-2.0.pdf
239456 RR_OtherProjectInfo_1_3-1.3.pdf
239456 PerformanceSite_2_0-2.0.pdf
Optional forms
239456 RR_SubawardBudget30_1_3-1.3.pdf
239456 PlannedReport-1.0.pdf
239456 PHS398_CumulativeInclusionReport-1.0.pdf
239456 PHS398_ModularBudget_1_2-1.2.pdf
239456 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
239456 RR_SF424_2_0-2.0.pdf
239456 PHS398_CoverPageSupplement_3_0-3.0.pdf
239456 RR_OtherProjectInfo_1_3-1.3.pdf
239456 PerformanceSite_2_0-2.0.pdf
239456 RR_KeyPersonExpanded_2_0-2.0.pdf
239456 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
239456 RR_Budget_1_3-1.3.pdf
239456 RR_SubawardBudget30_1_3-1.3.pdf
239456 PHS398_ModularBudget_1_2-1.2.pdf
239456 PHS_Inclusion_Enrollment_Report-1.0.pdf
239456 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
